Abstract
P.0073 The RECONNECT study: effectiveness of vortioxetine (10–20 mg/day) in patients with major depressive disorder comorbid with generalised anxiety disorder
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
